RE:RE:Mouse StudyPresented today ....
https://www.researchgate.net/publication/364746757_Potentiating_effect_of_reovirus_on_immune_checkpoint_inhibition_in_microsatellite_stable_colorectal_cancer
Therein the authors reported for the first time that immune-insensitive MSS tumors that account for 85% of all CRC can be effectively converted to immunotherapy-sensitive cancers by introducing reovirus to the therapeutic regimen - which certainly is a revelaltionary finding that will potentially have impact on how CRC can be treated using pelareorep + immune checkpoint inhibitors.